We are live on ! Find out more
GBIM

GLOBEIMMUNE INC COM STK (DE)
GBIM

Delisted

GBIM was delisted on the 22nd of July, 2016.

1 hedge funds and large institutions have $822K invested in GLOBEIMMUNE INC COM STK (DE) in 2016 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% less capital invested

Capital invested by funds: $1.4M → $822K (-$577K)

91% less funds holding

Funds holding: 111 (-10)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 10

Holders
1
Holders Change
-10
Holders Change %
-90.91%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
10
Calls
Puts
Net Calls
Net Calls Change

GBIM Hedge Fund Activity: Q3 2016 in Review

1 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in GLOBEIMMUNE INC COM STK (DE) (GBIM) for Q3 2016, worth a combined $822K — down 41% from $1.4M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of GBIM and 0 opened new positions — a net loss of 10 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vanguard Group, exiting entirely with an estimated $47K sold.

  • 1 institutional investor held GLOBEIMMUNE INC COM STK (DE) (GBIM) as of Q3 2016, down from 11 in Q2 2016.
  • Funds reported $822K of GLOBEIMMUNE INC COM STK (DE) stock for Q3 2016, down 41% quarter-over-quarter.
  • 0 funds opened new GLOBEIMMUNE INC COM STK (DE) positions in Q3 2016 and 10 closed out, a net change of -10 holders.
  • The largest GLOBEIMMUNE INC COM STK (DE) seller in Q3 2016 was Vanguard Group, an estimated $47K sold.

Based on aggregated 13F filings for Q3 2016.